The ArQule Advantage
Oncology
Exclusive
ACT platform
Industry validated
chemistry platform
Next
generation
cancer therapeutics
new mechanism
broad spectrum
first/best in class
selective
small molecule
Previous slide
Next slide
Back to first slide
View graphic version